Blood Substitute and Erythropoietin Therapy in a Severely Injured Jehovah's Witness
- 4 April 2002
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (14) , 1097-1098
- https://doi.org/10.1056/nejm200204043461420
Abstract
Since a 1945 church decision, Jehovah's Witnesses have refused blood transfusions, even in cases of life-threatening hemorrhage. As a result, physicians need to be aware of alternative therapeutic options for Jehovah's Witnesses.Keywords
This publication has 4 references indexed in Scilit:
- Resuscitation of the injured patient with polymerized stroma-free hemoglobin does not produce systemic or pulmonary hypertensionThe American Journal of Surgery, 1998
- The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgeryJournal of the American College of Surgeons, 1998
- Fluosol: Therapeutic Failure in severe AnemiaAnnals of Pharmacotherapy, 1993
- Acute Anaemia to a Haemoglobin of 14 g.l−1 with SurvivalAnaesthesia and Intensive Care, 1991